Tarsus Pharmaceuticals, Inc. TARS Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s total assets?
- Tarsus Pharmaceuticals, Inc. (TARS) reported total assets of $581.14M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s total assets changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s total assets increased by 16.1% year-over-year, from $500.75M to $581.14M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s total assets?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s total assets has grown at a 26.7% compound annual growth rate (CAGR), from $171.97M to $562.16M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.